help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 44, No. 5 963-967
doi:10.1210/jcem-44-5-963
Copyright © 1977 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HUHTANIEMI, I. T.
Right arrow Articles by JAFFE, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HUHTANIEMI, I. T.
Right arrow Articles by JAFFE, R. B.

hCG Binding and Stimulation of Testosterone Biosynthesis in the Human Fetal Testis

ILPO T. HUHTANIEMI1,2, CAROL C. KORENBROT1 and ROBERT B. JAFFE

Reproductive Endocrinology Center, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco San Francisco, California 94143

The role of hCG in the regulation of testicular steroid production in human fetuses from 14 to 20 weeks gestational age was studied. Saturable binding of l25I-hCG to testicular homogenates was demonstrated, and physiologic concentrations of hCG were able to stimulate testosterone formation in testicular minces without the addition of exogenous precursors. In five fetuses of 16–20 weeks gestational age, the capacity to bind hCG varied from 25.6 to 42.2 pg/mg wet tissue. The association constant of binding was 1.07±0.12x10M–1. Testicular minces from six other fetuses (gestational age 14–19 weeks) were incubated in the presence of concentrations of 0, 0.5, 5 or 50 ng/ml NIH-hCG (1 mg = 10,000 IU), which are within the physiologic range. Preincubation of 30 min in excess buffer was necessary to observe clear differences in testosterone production rates between controls and hCG stimulated testicular tissues. The greatest increase in testosterone production occurred when the hCG concentration was increased from 0.5 to 5 ng/ml. Little additional stimulation was observed at a concentration of 50 ng/ml. Maximal production rates of up to 12 ng/mg tissue/h were seen. It is concluded that human fetal testes bind hCG, and that physiologic levels of hCG stimulate fetal testicular testosterone formation in vitro at this stage of gestation.

Supported, in part, by NIH grant HD 08478 and a grant from The Rockefeller Foundation.

1 Fellow in Reproductive Endocrinology.

2 Supported by NIH International Research Fellowship No. F05-TW-2243.

Received September 20, 1976.




This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
N. A. Rahman and C.V. Rao
Recent progress in luteinizing hormone/human chorionic gonadotrophin hormone research
Mol. Hum. Reprod., November 1, 2009; 15(11): 703 - 711.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. A. Fowler, D. R. Abramovich, N. E. Haites, P. Cash, N. P. Groome, A. Al-Qahtani, T. J. Murray, and R. G. Lea
Human fetal testis Leydig cell disruption by exposure to the pesticide dieldrin at low concentrations
Hum. Reprod., November 1, 2007; 22(11): 2919 - 2927.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Lambrot, H. Coffigny, C. Pairault, A.-C. Donnadieu, R. Frydman, R. Habert, and V. Rouiller-Fabre
Use of Organ Culture to Study the Human Fetal Testis Development: Effect of Retinoic Acid
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2696 - 2703.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. A. Abdallah, Z. M. Lei, X. Li, N. Greenwold, S. T. Nakajima, E. Jauniaux, and Ch. V. Rao
Human Fetal Nongonadal Tissues Contain Human Chorionic Gonadotropin/Luteinizing Hormone Receptors
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 952 - 956.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Nakanishi, J. Kohroki, S. Suzuki, J. Ishizaki, Y. Hiromori, S. Takasuga, N. Itoh, Y. Watanabe, N. Utoguchi, and K. Tanaka
Trialkyltin Compounds Enhance Human CG Secretion and Aromatase Activity in Human Placental Choriocarcinoma Cells
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2830 - 2837.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
F.-P. Zhang, M. Poutanen, J. Wilbertz, and I. Huhtaniemi
Normal Prenatal but Arrested Postnatal Sexual Development of Luteinizing Hormone Receptor Knockout (LuRKO) Mice
Mol. Endocrinol., January 1, 2001; 15(1): 172 - 183.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
A. P. N. Themmen and I. T. Huhtaniemi
Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal Function
Endocr. Rev., October 1, 2000; 21(5): 551 - 583.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. S. Stavrou, Y.-S. Zhu, L.-Q. Cai, M. D. Katz, C. Herrera, M. DeFillo-Ricart, and J. Imperato-McGinley
A Novel Mutation of the Human Luteinizing Hormone Receptor in 46XY and 46XX Sisters
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2091 - 2098.
[Abstract] [Full Text]


Home page
ScienceHome page
W. McGregor, R. Kuhn, and R. Jaffe
Biologically active chorionic gonadotropin: synthesis by the human fetus
Science, April 15, 1983; 220(4594): 306 - 308.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1977 by The Endocrine Society